glp-1 for heart health The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action The Many Cardiovascular Benefits of

There is currently no established causal relationship between tirzepatide and tooth decay based on available clinical trial data and FDA-approved prescribing information

In another study, a double-blind, parallel-group trial was conducted in 72 adults with obesity, randomized to once-weekly subcutaneous semaglutide or placebo for 20 weeks

So functional ingredients that support gut health, like prebiotics, probiotics, any kind of fiber thats critical for these people

Researchers looked at data from 46,000 patients who had received a GLP-1 drug for at least six months, compared with 92,000 patients who had not taken these drugs

At present, the researchers do not recommend altering patient preparation or stopping GLP-1 agonists prior to FDG PET/CT scans